logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Colleen T O'Loughlin

This inventor holds 5 USPTO granted patents. Top assignee: Princeton University. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colleen T O'Loughlin. Retrieved from https://idiyas.com/inventor/colleen-t-o-loughlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Princeton, NJ (US) (2012 - 2015)
  • San Francisco, CA (US) (2016 - 2017)

Company Filing History:

goldMedal5 out of 1,134 
 
Princeton University
 patents

Years Active: 2012-2017

Loading Chart...
5 patents (USPTO):Explore Patents
1. 9751851 - Molecules and compositions that inhibit gram negative bacteria and their uses (2017-09-05),
2. 9468624 - Small molecule antagonists of bacterial quorum-sensing receptors (2016-10-18),
3. 9084773 - Small molecule antagonists of bacterial quorum-sensing receptors (2015-07-21),
4. 8772331 - Small molecule antagonists of bacterial quorum-sensing receptors (2014-07-08),
5. 8247443 - Small molecule antagonists of bacterial quorum-sensing receptors (2012-08-21),

Title: Innovations by Colleen T O'Loughlin

Introduction

Colleen T O'Loughlin is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of antimicrobial research, focusing on innovative strategies to combat gram-negative bacteria. With a total of 5 patents, her work has garnered attention for its potential applications in medical and environmental settings.

Latest Patents

O'Loughlin's latest patents include groundbreaking molecules and compositions that inhibit gram-negative bacteria and their uses. One of her strategies involves the synthesis of a series of compounds that inhibit the production of pyocyanin, a virulence factor produced by this pathogen. Additionally, she has developed compounds that inhibit the two quorum-sensing receptors, LasR and RhlR, which play a crucial role in biofilm formation and virulence. Another notable patent features a novel small molecule that antagonizes two types of acyl homoserine lactone receptors, providing a protective mechanism against quorum-sensing-mediated killing by bacterial pathogens.

Career Highlights

Colleen T O'Loughlin is affiliated with Princeton University, where she conducts her research and develops her innovative solutions. Her work has not only advanced scientific understanding but also opened new avenues for antimicrobial therapies.

Collaborations

O'Loughlin collaborates with esteemed colleagues such as Bonnie L Bassler and Lee R Swem, contributing to a rich environment of innovation and discovery.

Conclusion

Colleen T O'Loughlin's contributions to antimicrobial research exemplify the impact of innovative thinking in addressing critical health challenges. Her patents reflect a commitment to advancing science and improving public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…